Stable pharmaceutical formulations of methylnaltrexone | Patent Number 10376584

US 10376584 B2
Application Number15474614
Publication NumberUS 20170258911 A1
Pendency2 years, 4 months, 16 days
Filled DateMar 30, 2017
Priority DateApr 8, 2003
Publication DateSep 14, 2017
Expiration DateApr 8, 2023
Inventor/ApplicantsSuketu P. Sanghvi
Thomas A. Boyd
ExaminesLEE, WILLIAM Y
Art Unit1629
Technology Center1600
Assignments
Progenics Pharmaceuticals
Current
Progenics PharmaceuticalsLantheus Holdings Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.